malondialdehyde has been researched along with imatinib mesylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ammar, M; Ben Mahmoud, L; Elloumi, M; Ghozzi, H; Hakim, A; Medhaffar, M; Mseddi, M; Sahnoun, Z; Zeghal, K | 1 |
| Harahap, A; Jusman, SW; Reksodiputro, AH; Rinaldi, I; Setiabudy, R; Suharti, C; Tambunan, K; Wanandi, SI | 1 |
| Said, E; Salem, HA; Samaha, MM | 1 |
3 other study(ies) available for malondialdehyde and imatinib mesylate
| Article | Year |
|---|---|
Relationship of oxidative stress in the resistance to imatinib in Tunisian patients with chronic myeloid leukemia: A retrospective study.
Topics: Adult; Advanced Oxidation Protein Products; Antineoplastic Agents; Antioxidants; Ascorbic Acid; Case-Control Studies; Drug Resistance, Neoplasm; Enzymes; Female; Glutathione; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Treatment Outcome; Tunisia | 2020 |
Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Sectional Studies; Female; Humans; Hydroxyurea; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Malondialdehyde; Middle Aged; Protein Kinase Inhibitors; Retrospective Studies; Young Adult | 2019 |
Modulatory role of imatinib mesylate on pancreatic β-cells' secretory functions in an STZ rat model of diabetes mellitus.
Topics: Administration, Oral; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antioxidants; Biomarkers; Blood Glucose; Body Weight; Caspase 3; Catalase; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucagon; Glutathione; Imatinib Mesylate; Insulin; Insulin-Secreting Cells; Male; Malondialdehyde; Organ Size; Oxidation-Reduction; Oxidative Stress; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase | 2020 |